RecruitingPhase 4NCT06797973

Efficacy and Safety of Intrathecal Morphine for Postoperative Pain Management Following Planned Caesarean Section

Studying Opsoclonus-myoclonus syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Anne Juul Wikkelsø
Intervention
Intrathecal Morphine(drug)
Enrollment
1312 target
Eligibility
18 years · FEMALE
Timeline
20252027

Study locations (8)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06797973 on ClinicalTrials.gov

Other trials for Opsoclonus-myoclonus syndrome

Additional recruiting or active studies for the same condition.

See all trials for Opsoclonus-myoclonus syndrome

← Back to all trials